Characterization of the Histoplasma capsulatum-induced granuloma.
Rising rates of Histoplasma capsulatum infection are an emerging problem among the rapidly growing population of immune-compromised individuals. Although there is a growing understanding of systemic immunity against Histoplasma, little is known about the local granulomatous response, which is an important component in the control of infection. The focus of this article is the characterization of Histoplasma-induced granulomas. Five days after i.p. infection, infected macrophage appear in the liver and lung; however, no granulomas are apparent. Two days later, well-formed sarcoid granulomas are abundant in the lung and liver of infected mice, which contain all visible Histoplasma. Granulomas are dominated by macrophage and lymphocytes. Most of the Histoplasma and most of the apoptotic cells are found in the center of the lesions. We isolated liver granulomas at multiple time points after infection and analyzed the cellular composition, TCR gene usage, and cytokine production of granuloma-infiltrating cells. The lesions contain both CD4+ and CD8+ T cell subsets, and T cells are the primary source of IFN-gamma and IL-17. The main source of local TNF-alpha is macrophage. Chemokines are produced by both infiltrating macrophage and lymphocytes. Dendritic cells are present in granulomas; however, T cell expansion seems to occur systemically because TCR usage is very heterogeneous even at the level of individual lesions. This study is the first direct examination of host cellular responses in the Histoplasma-induced granuloma representing the specific interface between host and pathogen. Our studies will allow further analysis of key elements of host Histoplasma interactions at the site of chronic infection.
Heninger
Erika
E
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison 53706, USA.
Hogan
Laura H
LH
Karman
Jozsef
J
Macvilay
Sinarack
S
Hill
Bjork
B
Woods
Jon P
JP
Sandor
Matyas
M
D000818:Animals; D017209:Apoptosis; D018925:Chemokines / Q000096:biosynthesis; D016207:Cytokines / Q000096:biosynthesis; D003713:Dendritic Cells / Q000276:immunology; D006099:Granuloma / Q000150:complications / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D006658:Histoplasma / Q000502:physiology*; D006660:Histoplasmosis / Q000150:complications / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D007274:Injections, Intraperitoneal; D007700:Kinetics; D008099:Liver / Q000276:immunology / Q000473:pathology; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D010641:Phenotype; D011948:Receptors, Antigen, T-Cell / Q000276:immunology / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism
D018925:Chemokines; D016207:Cytokines; D011948:Receptors, Antigen, T-Cell